期刊文献+

感染性疾病中血清降钙素原和C反应蛋白检测的临床意义 被引量:18

The clinical significance of serum procalcitonin and C-restive protein in diagnosis of infection disease
下载PDF
导出
摘要 目的分析感染性疾病中血清降钙素原(PCT)和C反应蛋白(CRP)的临床意义。方法检测200例感染性疾病及80例非感染性疾病患者血清中的PCT和CRP含量。结果治疗前细菌感染组120例患者PCT测定值为(23.3±7.8)μg/L,CRP为(26.7±17.1)mg/L;治疗后PCT为(2.1±0.7)μg/L,CRP为(4.9±0.9)mg/L,治疗前后差异有显著性(P〈0.01)。细菌感染组和病毒感染组、非感染组比较差异有显著性(P〈0.01)。结论在感染时,PCT和CRP检测对于疾病的鉴别与诊断有很大的作用,对其进行动态检测对于疗效判断有一定的临床意义与价值。 Objective To explore the clinical significance of serum procalcitonin ( PCT ) and C-reactive protein( CRP ) in the diagnosis of infection disease. Methods Serum PCT and CRP results were analyzed in 200 patients with infection disease and 80 patients with no-infection disease. Results Serum PCT of 120 patients with bacterium infection before and after treatment were( 23.3 ±7.8)μ/L and (2.1 ±0.7)μ g/L, respectively; and serum CRPwere (26.7 ± 17.1 ) mg/Land (4.9 ± 0.9) mg/L; serum PCT and CRP of the patients with bacterium infection after treatment significantly differed from that before treatment ( P 〈 0.01 ). Serum PCT and CRP of patients with bacterium infection was significantly higher than that of patients with virus infection or no infection ( P 〈 0.01 ). Conclusions During infection, the combination test of PCT and CRP play an important role on the differentiation and diagnosis of diseases. Dynamically testing them has some certain clinical significance and value in the assessment of curative efficacy.
出处 《国际医药卫生导报》 2012年第5期695-697,共3页 International Medicine and Health Guidance News
关键词 感染性疾病 降钙素原 C反应蛋白 临床意义 Infection disease Procalcitonin C-reactive protein clinical significance
  • 相关文献

参考文献6

二级参考文献38

  • 1刘景春,王镇山,薛欣,顾俊明.血清降钙素原对肝硬化并发自发性细菌性腹膜炎的诊断价值[J].大连医科大学学报,2006,28(3):201-202. 被引量:13
  • 2常春,姚婉贞,陈亚红,刘振英,张晓伟.慢性阻塞性肺疾病患者急性加重期血清降钙素原水平的变化及临床意义[J].中华结核和呼吸杂志,2006,29(7):444-447. 被引量:93
  • 3左震华,蔡少华,李洪霞,刘长庭,俞森洋.降钙素原对呼吸机相关性肺炎诊断及预后判断的临床意义[J].中华医院感染学杂志,2006,16(12):1353-1355. 被引量:34
  • 4张智洁,刘勇,孙继梅,周秀珍,刘建华,梁再赋.头孢他啶影响大鼠降钙素原产生机制的初步研究[J].中华医院感染学杂志,2007,17(2):129-133. 被引量:14
  • 5中华人民共和国卫生部,医院感染诊断标准[s].北京:中华人民共和国卫生部,2001.
  • 6UZZAN B, COHEN R, NICOLAS P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill aduhs and after surgery or trauma: a systematic review and meta-analysis [ J ]. Crit Care Med, 2006, 34(7) : 1996 -2003.
  • 7LEVY M M, FINK M P, MARSHALL J C, et al. 2001 SCCM/ ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J]. Crit Care Med, 2003, 31(4) : 1250-1256.
  • 8BONE R C, BALK R A, CERRA F B, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J]. Chest, 1992, 101(6): 1644-1655.
  • 9STOLZ D, CHRIST CRAIN M, BINGISSER R, et al. Antibiotic treatment of exacerbations of COPD : a randomized cont rolled trialcomparing procalcitonin guidance with standard therapy [ J ]. Chest, 2007, 131(1): 9-19.
  • 10MANIACI V, DAUBER A, WEISS S, et al. Procalcitonin in young febrile infants for the detection of serious bacterial infections [J]. Pediatrics, 2008, 122(4) : 701 -710.

共引文献259

同被引文献146

  • 1樊宇荣.感染性休克患者早期目标导向治疗的临床应用[J].实用医学杂志,2009,25(5):733-735. 被引量:7
  • 2王守义.肝硬化自发性细菌性腹膜炎的诊断和治疗[J].临床肝胆病杂志,2006,22(1):19-21. 被引量:40
  • 3杜伟鹏,胡旭.急性胰腺炎实验室诊断指标的比较[J].中国厂矿医学,2006,19(2):120-121. 被引量:2
  • 4Schwarz S,Bertram M,Schwab S,et al.Serum procalcitoninlevels in bacterial and abacterial meningitis[J].Crit CareMed, 2000, 28(6): 1828-1832.
  • 5Levy MM, Fink MP, Marshall JC, et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis DefinitionsConference[J].Intensive Care Med, 2003, 29(4): 530-538.
  • 6张代民.降钙素原的测定与临床应用进展[J].实用医药杂志,2007,24(5):619-622. 被引量:57
  • 7Dellinger, R.P., M.M. Levy, A. Rhodes, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012[J]. Crit Care Med, 2013, 41(2): 580-637.
  • 8Martin, G.S., D.M. Mannino, S. Eaton, et al. The epidemiology of sepsis in the United States from 1979 through 2000[J]. N Engl J Med, 2003, 348(16): 1546- 1554.
  • 9Vesteinsdottir, E., S. Karason, S.E. Sigurdsson, et al. Severe sepsis and septic shock: a prospective population- based study in Icelandic intensive care units[J]. Acta Anaesthesiol Scand, 2011, 55(6): 722-731.
  • 10Rivers, E.P., J.A. Kruse, G. Jacobsen, et al. The influence of early hemodynamic optimization on hiomarker patterns of severe sepsis and septic shock[J]. Critical Care Medicine, 2007, 35(9): 2016-2024.

引证文献18

二级引证文献116

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部